AlphaSpec(TM) uL Spectrophotometer Now Available from Alpha Innotech Corp.

SAN LEANDRO, Calif.--(Business Wire)--
The new AlphaSpec(TM) uL Spectrophotometer is now available from
Alpha Innotech Corp. (OTCBB:APNO), a leading provider of innovative
bioimaging solutions for a broad range of life science applications.
AlphaSpec's innovative sample platform features a non-contact
detection method allowing scientists to recover 100% of their sample
after taking a measurement. Additionally, AlphaSpec only requires 2 uL
of sample for measurement, eliminating the need for dilutions,
cuvettes or capillaries.

AlphaSpec is a compact UV/Vis spectrophotometer providing superior
performance and an intuitive workflow. AlphaSpec's in-tip detection
design allows the user to simply pipette 2 ul of sample into the
pipette tip which is then placed into the AlphaSpec for analysis.
Since the reading takes place through the pipette tip, the scientist
can recover 100% of their sample for further experimentation. This
streamlined sample measurement process is enabled by the development
of AlphaUV(TM) tips which are constructed of a transmissive polymer,
allowing direct in-tip detection and eliminating the need to transfer
the sample to a cuvette or a capillary.

"AlphaSpec is an ideal spectrophotometer for daily use in
laboratories requiring quick preprogrammed analysis modules.
Additionally, the ability to recover samples following measurement is
a very important benefit for life science researchers because it
allows them to conserve precious sample," commented Lisa Valdin,
Marketing Manager of Alpha Innotech.

AlphaSpec is designed for applications involving DNA, RNA,
protein, cell density and microarray sample absorption measurements.
AlphaSpec's advanced CCD detector can analyze samples with wavelengths
ranging from 230 to 850 nm, with the resulting scan displayed as a
graph of the spectral curve. AlphaSpec's intuitive user interface
employs established protocols for automatically calculating valuable
data such as concentration, absorbance, dye ratios and purity ratios.

"Alpha Innotech has always been at the forefront of bringing
innovative instruments to the life science research and molecular
biology markets," stated Sia Ghazvini, VP of Marketing and Business
Development, "and with the release of AlphaSpec we now offer a unique,
productivity-driven instrument for new customers in teaching
institutions and the food industry."

Supporting the launch of the AlphaSpec is AlphaCal(TM), a DNA
wavelength calibration kit for Good Laboratory Practice
(GLP)-compliant analysis. This unique calibration fluid comes with an
independent NIST- traceable certification, and provides a reliable and
accurate reference point for calibrating the AlphaSpec when used for
applications within the UV/Visible spectrum. This product will allow
GLP labs to validate the system using a NIST traceable standard.

For more information on AlphaSpec please visit
www.alphainnotech.com. The instrument and supporting reagents and
consumables are available for purchase online at Alpha Innotech's
website.

About Alpha Innotech Corp.

Founded in 1992 and with over 10,000 systems sold worldwide, Alpha
Innotech is a leading developer, manufacturer and marketer of digital
imaging and analysis systems for the life science research and drug
discovery markets. Our goal is to combine instruments, reagents and
bioinformatics software to offer integrated modular technology
platforms for functional genomics, proteomics and cell analysis
markets. Our customers include pharmaceutical and biotechnology
companies as well as universities, medical centers, government
research institutes and agencies worldwide. More information on Alpha
Innotech can be found at the Company's website www.alphainnotech.com.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934 and is subject to the safe
harbor created by those sections. These forward-looking statements
involve a number of risks and uncertainties that include, but are not
limited to, the Company's ability to obtain additional financing if
needed, the timing of the introduction and success of new products,
and the Company's growth prospects, that could cause actual results to
differ materially from those anticipated or planned by these
forward-looking statements. Please also refer to the risk factors
described in our filings with the Securities and Exchange Commission,
including our recent Form 10-KSB and Forms10-QSB filed with the
Securities and Exchange Commission. We do not intend to update the
forward-looking information contained in this news release except as
required by law.

AlphaSpec(TM), AlphaCal(TM) and AlphaUV(TM) are trademarks of
Alpha Innotech Corp. All other trademarks and tradenames appearing in
this document are the property of their respective owner.

Alpha Innotech Corp.
Ron Bissinger, CEO, 510-483-9620

Copyright Business Wire 2008